TM
Mammoth Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MB-111 | Undisclosed | Preclinical |
| NanoCas for Extrahepatic Editing | Potential muscular/other disorders | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| MB-111 | Undisclosed | Preclinical |
| NanoCas for Extrahepatic Editing | Potential muscular/other disorders | Preclinical |